Biological Factors - Factor VIII PubMed MeSh Term

Overview

subject area of

• Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A.  Journal Article
• Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.  Journal Article